Globus Medical, Inc.

Healthcare

NYSE:GMED · New York Stock Exchange

Market Cap $10.47B Beta 0.95 P/E (TTM) 17.4

$79.23 -2.71%

-$2.10 today

52W Low $51.79High $101.40

Vol 1.79M · Avg 1.45M

EPS (TTM) $4.33Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+37.05%

Period High

$96.82

Period Low

$51.89

Latest

$79.23

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.52B

Penumbra, Inc.

NYSE:PEN

$12.44B

Align Technology, Inc.

NASDAQ:ALGN

$12.43B

Molina Healthcare, Inc.

NYSE:MOH

$10.19B

Henry Schein, Inc.

NASDAQ:HSIC

$9.11B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.70B

AptarGroup, Inc.

NYSE:ATR

$7.66B

HealthEquity, Inc.

NASDAQ:HQY

$7.22B

Grifols, S.A.

NASDAQ:GRFS

$6.31B

What is the latest GMED filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does GMED have?

Intrinsic Alpha currently shows 20 recent filings for GMED.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.